Prothena (PRTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Biogen, Eli Lilly's, Prothena and AC Immune are included in this Analyst Blog.